Can Panax ginseng help control cytokine storm in COVID-19?

Pollard, 2020, The COVID-19 pandemic: a global health crisis, Physiol Genom, 52, 549, 10.1152/physiolgenomics.00089.2020 Yin, 2018, MERS, SARS and other coronaviruses as causes of pneumonia, Respirology, 23, 130, 10.1111/resp.13196 Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7 Yang, 2020, COVID-19: immunopathogenesis and Immunotherapeutics, Signal Transduc Targe Ther, 5, 1 Costela-Ruiz, 2020, SARS-CoV-2 infection: the role of cytokines in COVID-19 disease, Cytokine Growth Factor Rev, 54, 62, 10.1016/j.cytogfr.2020.06.001 Yang, 2021, The signal pathways and treatment of cytokine storm in COVID-19, Signal Transduct Target Ther, 6, 255, 10.1038/s41392-021-00679-0 McIntosh, 2020 Sapra, 2021, Phytotherapy for treatment of cytokine storm in COVID-19, Front Biosci (Landmark Ed), 26, 51, 10.52586/4924 Fajgenbaum, 2020, Cytokine storm, N Engl J Med, 383, 2255, 10.1056/NEJMra2026131 Del Valle, 2020, An inflammatory cytokine signature predicts COVID-19 severity and survival, Nat Med, 26, 1636, 10.1038/s41591-020-1051-9 Tang, 2020, Controlling cytokine storm is vital in COVID-19, Front Immunol, 11, 570993, 10.3389/fimmu.2020.570993 Singh, 2020, Drug repurposing approach to fight COVID-19, Pharmacol Rep, 72, 1479, 10.1007/s43440-020-00155-6 Tang, 2020, Cytokine storm in COVID-19: the current evidence and treatment strategies, Front Immunol, 11, 1708, 10.3389/fimmu.2020.01708 Desjarlais, 2020, Nutraceutical targeting of inflammation-modulating microRNAs in severe forms of COVID-19: a novel approach to prevent the cytokine storm, Front Pharmacol, 11, 602999, 10.3389/fphar.2020.602999 Hoffmann, 2020, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell, 181, 271, 10.1016/j.cell.2020.02.052 Hoffmann, 2020, A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells, Mol Cell, 78, 779, 10.1016/j.molcel.2020.04.022 Yang, 2020, Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development, medRxiv Yang, 2020, SARS-CoV-2 infection and the antiviral innate immune response, J Mol Cell Biol, 12, 963 Sette, 2021, Adaptive immunity to SARS-CoV-2 and COVID-19, Cell, 184, 861, 10.1016/j.cell.2021.01.007 Coperchini, 2020, The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system, Cytokine Growth Factor Rev, 53, 25, 10.1016/j.cytogfr.2020.05.003 Ruan, 2020, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China, Intensive Care Med, 46, 846, 10.1007/s00134-020-05991-x Billing, 2019, Robustness and information transfer within IL-6-induced JAK/STAT signalling, Commun Biol, 2, 27, 10.1038/s42003-018-0259-4 Luo, 2020, Targeting JAK-STAT signaling to control cytokine release syndrome in COVID-19, Trends Pharmacol Sci, 41, 531, 10.1016/j.tips.2020.06.007 Giang, 2018, Dengue hemophagocytic syndrome: a systematic review and meta-analysis on epidemiology, clinical signs, outcomes, and risk factors, Rev Med Virol, 28, 10.1002/rmv.2005 Gadotti, 2020, IFN-gamma is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection, Virus Res, 289, 198171, 10.1016/j.virusres.2020.198171 Bianchi, 2000, Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids, Proc Natl Acad Sci U S A, 97, 9573, 10.1073/pnas.160099797 Grasshoff, 2021, Low-dose IL-2 therapy in autoimmune and rheumatic diseases, Front Immunol, 12, 648408, 10.3389/fimmu.2021.648408 Hayden, 2014, Regulation of NF-kappaB by TNF family cytokines, Semin Immunol, 26, 253, 10.1016/j.smim.2014.05.004 Kircheis, 2020, NF-kappaB pathway as a potential target for treatment of critical stage COVID-19 patients, Front Immunol, 11, 598444, 10.3389/fimmu.2020.598444 Tay, 2020, The trinity of COVID-19: immunity, inflammation and intervention, Nat Rev Immunol, 20, 363, 10.1038/s41577-020-0311-8 Diao, 2020, Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19), Front Immunol, 11, 827, 10.3389/fimmu.2020.00827 Mortaz, 2021, Increased serum levels of soluble TNF-alpha receptor is associated with ICU mortality in COVID-19 patients, Front Immunol, 12, 592727, 10.3389/fimmu.2021.592727 Mosser, 2008, Interleukin-10: new perspectives on an old cytokine, Immunol Rev, 226, 205, 10.1111/j.1600-065X.2008.00706.x Nagata, 2021, IL-10 in mast cell-mediated immune responses: anti-inflammatory and proinflammatory roles, Int J Mol Sci, 22 Han, 2020, Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors, Emerg Microb Infect, 9, 1123, 10.1080/22221751.2020.1770129 Steen, 2020, The role of the anti-inflammatory cytokine interleukin-10 in tissue fibrosis, Adv Wound Care, 9, 184, 10.1089/wound.2019.1032 McGinley, 2020, Interleukin-17A serves a priming role in autoimmunity by recruiting IL-1beta-producing myeloid cells that promote pathogenic T cells, Immunity, 52, 342, 10.1016/j.immuni.2020.01.002 Hamza, 2010, Interleukin 12 a key immunoregulatory cytokine in infection applications, Int J Mol Sci, 11, 789, 10.3390/ijms11030789 Iwakura, 2008, The roles of IL-17A in inflammatory immune responses and host defense against pathogens, Immunol Rev, 226, 57, 10.1111/j.1600-065X.2008.00699.x Li, 2016, Blockade of interleukin-17 restrains the development of acute lung injury, Scand J Immunol, 83, 203, 10.1111/sji.12408 Mendoza, 2020, Interleukin-17: a potential therapeutic target in COVID-19, J Infect, 81, e136 Asrani, 2021, SARS-CoV-2 mediated lung inflammatory responses in host: targeting the cytokine storm for therapeutic interventions, Mol Cell Biochem, 476, 675, 10.1007/s11010-020-03935-z Avdeev, 2021, Anti-IL-17 monoclonal antibodies in hospitalized patients with severe COVID-19: a pilot study, Cytokine, 146, 155627, 10.1016/j.cyto.2021.155627 Cho, 2012, Effects of Panax ginseng in neurodegenerative diseases, J Ginseng Res, 36, 342, 10.5142/jgr.2012.36.4.342 Lee, 2019, Panax ginseng: a candidate herbal medicine for autoimmune disease, J Ginseng Res, 43, 342, 10.1016/j.jgr.2018.10.002 Sng, 2022, Ginseng extract and ginsenosides improve neurological function and promote antioxidant effects in rats with spinal cord injury: a meta-analysis and systematic review, J Ginseng Res, 46, 11, 10.1016/j.jgr.2021.05.009 Im, 2016, Ginseng, the natural effectual antiviral: protective effects of Korean Red Ginseng against viral infection, J Ginseng Res, 40, 309, 10.1016/j.jgr.2015.09.002 Lee, 2021, Corona-Cov-2 (COVID-19) and ginseng: comparison of possible use in COVID-19 and influenza, J Ginseng Res, 45, 535, 10.1016/j.jgr.2020.12.005 Hu, 2022, A review of the immunomodulatory activities of polysaccharides isolated from Panax species, J Ginseng Res, 46, 23, 10.1016/j.jgr.2021.06.003 Yang, 2021, Phytochemical analysis of Panax species: a review, J Ginseng Res, 45, 1, 10.1016/j.jgr.2019.12.009 Shin, 2020, Korean red ginseng plays an anti-aging role by modulating expression of aging-related genes and immune cell subsets, Molecules, 25, 10.3390/molecules25071492 Lee, 2015, Ginseng protects against respiratory syncytial virus by modulating multiple immune cells and inhibiting viral replication, Nutrients, 7, 1021, 10.3390/nu7021021 Lee, 2014, Antiviral activity of ginseng extract against respiratory syncytial virus infection, Int J Mol Med, 34, 183, 10.3892/ijmm.2014.1750 Wang, 2020, Advances in the chemistry, pharmacological diversity, and metabolism of 20(R)-ginseng saponins, J Ginseng Res, 44, 14, 10.1016/j.jgr.2019.01.005 Kim, 2021, The effect of ginsenosides on depression in preclinical studies: a systematic review and meta-analysis, J Ginseng Res, 45, 420, 10.1016/j.jgr.2020.08.006 Ratan, 2021, Pharmacological potential of ginseng and its major component ginsenosides, J Ginseng Res, 45, 199, 10.1016/j.jgr.2020.02.004 Lorz, 2020, Medicinal potential of Panax ginseng and its ginsenosides in atopic dermatitis treatment, J Ginseng Res, 44, 8, 10.1016/j.jgr.2018.12.012 Park, 2021, The antioxidant activities of Korean Red Ginseng (Panax ginseng) and ginsenosides: a systemic review through in vivo and clinical trials, J Ginseng Res, 45, 41, 10.1016/j.jgr.2020.09.006 Iqbal, 2020, Ginseng alleviates microbial infections of the respiratory tract: a review, J Ginseng Res, 44, 194, 10.1016/j.jgr.2019.12.001 Chen, 2021, Protection by ginseng saponins against cyclophosphamide-induced liver injuries in rats by induction of cytochrome P450 expression and mediation of the l-arginine/nitric oxide pathway based on metabolomics, Phytother Res, 35, 3130, 10.1002/ptr.6951 Aravinthan, 2021, Ginsenoside Rb1 inhibits monoiodoacetate-induced osteoarthritis in postmenopausal rats through prevention of cartilage degradation, J Ginseng Res, 45, 287, 10.1016/j.jgr.2020.01.004 Lu, 2020, Ginsenoside Rb1 can ameliorate the key inflammatory cytokines TNF-alpha and IL-6 in a cancer cachexia mouse model, BMC Compl Med Ther, 20, 11, 10.1186/s12906-019-2797-9 Jiang, 2015, Ginsenoside Rb1 treatment attenuates pulmonary inflammatory cytokine release and tissue injury following intestinal ischemia reperfusion injury in mice, Oxid Med Cell Longev, 2015, 843721, 10.1155/2015/843721 Huang, 2021, Ginsenoside Rg3 ameliorates allergic airway inflammation and oxidative stress in mice, J Ginseng Res, 46, 654, 10.1016/j.jgr.2021.03.002 Yang, 2018, Ginsenoside Rg3 attenuates lipopolysaccharide-induced acute lung injury via MerTK-dependent activation of the PI3K/AKT/mTOR pathway, Front Pharmacol, 9, 850, 10.3389/fphar.2018.00850 Cho, 2019, Enhanced Rg3 negatively regulates Th1 cell responses, J Ginseng Res, 43, 49, 10.1016/j.jgr.2017.08.003 Paik, 2019, Rg6, a rare ginsenoside, inhibits systemic inflammation through the induction of interleukin-10 and microRNA-146a, Sci Rep, 9, 4342, 10.1038/s41598-019-40690-8 Li, 2021, Ginsenoside Rh1 attenuates ovalbumin-induced asthma by regulating Th1/Th2 cytokines balance, Biosci Biotechnol Biochem, 85, 1809, 10.1093/bbb/zbab099 Huynh, 2020, Minor ginsenoside Rg2 and Rh1 attenuates LPS-induced acute liver and kidney damages via downregulating activation of TLR4-STAT1 and inflammatory cytokine production in macrophages, Int J Mol Sci, 21 Yu, 2017, Ginsenoside Rk1 suppresses pro-inflammatory responses in lipopolysaccharide-stimulated RAW264.7 cells by inhibiting the Jak2/Stat3 pathway, Chin J Nat Med, 15, 751 Bai, 2021, Ginsenoside Rk3 alleviates gut microbiota dysbiosis and colonic inflammation in antibiotic-treated mice, Food Res Int, 146, 110465, 10.1016/j.foodres.2021.110465 Ju, 2020, Diol-ginsenosides from Korean Red Ginseng delay the development of type 1 diabetes in diabetes-prone biobreeding rats, J Ginseng Res, 44, 619, 10.1016/j.jgr.2019.06.001 Hyun, 2020, Physiological and pharmacological features of the non-saponin components in Korean Red Ginseng, J Ginseng Res, 44, 527, 10.1016/j.jgr.2020.01.005 Park, 2020, The non-saponin fraction of Korean Red Ginseng (KGC05P0) decreases glucose uptake and transport in vitro and modulates glucose production via down-regulation of the PI3K/AKT pathway in vivo, J Ginseng Res, 44, 362, 10.1016/j.jgr.2019.12.004 Ahn, 2019, Nonsaponin fraction of Korean Red Ginseng attenuates cytokine production via inhibition of TLR4 expression, J Ginseng Res, 43, 291, 10.1016/j.jgr.2018.03.003 Yoo, 2012, Protective effect of ginseng polysaccharides on influenza viral infection, PLoS One, 7, e33678, 10.1371/journal.pone.0033678 Yin, 2013, A comparative study of the effects of whole red ginseng extract and polysaccharide and saponin fractions on influenza A (H1N1) virus infection, Biol Pharm Bull, 36, 1002, 10.1248/bpb.b13-00123 Lee, 2019, Immunostimulating and antimetastatic effects of polysaccharides purified from ginseng berry, Am J Chin Med, 47, 823, 10.1142/S0192415X19500435 Hwang, 2018, Immunoadjuvant activity in mice of polysaccharides isolated from the leaves of Panax ginseng C.A. Meyer, Int J Biol Macromol, 107, 2695, 10.1016/j.ijbiomac.2017.10.160 Xi, 2017, Effect of ginseng polysaccharides on the immunity and growth of piglets by dietary supplementation during late pregnancy and lactating sows, Anim Sci J, 88, 863, 10.1111/asj.12678 Hwang, 2011, An acidic polysaccharide of Panax ginseng ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells, Immunol Lett, 138, 169, 10.1016/j.imlet.2011.04.005 Kim, 1998, Acidic polysaccharide from Panax ginseng, ginsan, induces Th1 cell and macrophage cytokines and generates LAK cells in synergy with rIL-2, Planta Med, 64, 110, 10.1055/s-2006-957385 Moon, 2021, p-coumaric acid, an active ingredient of Panax ginseng, ameliolates atopic dermatitis-like skin lesions through inhibition of thymic stromal lymphopoietin in mice, J Ginseng Res, 45, 176, 10.1016/j.jgr.2020.06.004 Choi, 2021, Ginseng gintonin, aging societies, and geriatric brain diseases, Integr Med Res, 10, 100450, 10.1016/j.imr.2020.100450 Kim, 2021, Gintonin regulates inflammation in human IL-1β-stimulated fibroblast-like synoviocytes and carrageenan/kaolin-induced arthritis in rats through LPAR2, J Ginseng Res, 45, 575, 10.1016/j.jgr.2021.02.001 Choi, 2021, Gintonin mitigates experimental autoimmune encephalomyelitis by stabilization of Nrf2 signaling via stimulation of lysophosphatidic acid receptors, Brain Behav Immun, 93, 384, 10.1016/j.bbi.2020.12.004 Jang, 2019, Gintonin, a ginseng-derived ingredient, as a novel therapeutic strategy for Huntington's disease: activation of the Nrf2 pathway through lysophosphatidic acid receptors, Brain Behav Immun, 80, 146, 10.1016/j.bbi.2019.03.001 Choi, 2018, Multi-target protective effects of gintonin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Mediated model of Parkinson's disease via lysophosphatidic acid receptors, Front Pharmacol, 9, 515, 10.3389/fphar.2018.00515 Chei, 2020, Gintonin-enriched fraction suppresses heat stress-induced inflammation through LPA receptor, Molecules, 25, 10.3390/molecules25051019 Katouzian, 2016, Nano-encapsulation as a promising approach for targeted delivery and controlled release of vitamins, Trends Food Sci Technol, 53, 34, 10.1016/j.tifs.2016.05.002 Liu, 2020, Anti-inflammatory and anti-gouty-arthritic effect of free Ginsenoside Rb1 and nano Ginsenoside Rb1 against MSU induced gouty arthritis in experimental animals, Chem Biol Interact, 332, 109285, 10.1016/j.cbi.2020.109285 Karmazyn, 2021, Chemical components of ginseng, their biotransformation products and their potential as treatment of hypertension, Mol Cell Biochem, 476, 333, 10.1007/s11010-020-03910-8 Bae, 2021, Fermented red ginseng alleviates ovalbumin-induced inflammation in mice by suppressing interleukin-4 and immunoglobulin E expression, J Med Food, 24, 569, 10.1089/jmf.2020.4854 Fan, 2021, Fermented ginseng attenuates lipopolysaccharide-induced inflammatory responses by activating the TLR4/MAPK signaling pathway and remediating gut barrier, Food Funct, 12, 852, 10.1039/D0FO02404J Hyun, 2021, Immuno-enhancement effects of Korean Red Ginseng in healthy adults: a randomized, double-blind, placebo-controlled trial, J Ginseng Res, 45, 191, 10.1016/j.jgr.2020.08.003 Jung, 2011, Effects of Panax ginseng supplementation on muscle damage and inflammation after uphill treadmill running in humans, Am J Chin Med, 39, 441, 10.1142/S0192415X11008944 Hou, 2015, Improved inflammatory balance of human skeletal muscle during exercise after supplementations of the ginseng-based steroid Rg1, PLoS One, 10, e0116387, 10.1371/journal.pone.0116387 Ma, 2014, Effect of ginseng polysaccharides and dendritic cells on the balance of Th1/Th2 T helper cells in patients with non-small cell lung cancer, J Tradit Chin Med, 34, 641 Jung, 2020, The effect of Korean red ginseng on symptoms and inflammation in patients with allergic rhinitis, Ear Nose Throat J Huang, 2021, Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: efficacies and mechanisms, Pharmacol Ther, 225, 107843, 10.1016/j.pharmthera.2021.107843